Although the anti-angiogenic activity of CMCs has not been sufficiently explored, we have previously shown that CMC2.24 suppressed VEGF secretion in malignant oral cancer cells [57]. The gene discussed is VEGFA; the disease is lip and oral cavity carcinoma.